Evidence map›Paper›PMID 34454883›Full record

Trial reportJACC. Clinical electrophysiology2021

Using Machine-Learning for Prediction of the Response to Cardiac Resynchronization Therapy: The SMART-AV Study.

Stacey J Howell, Tim Stivland, Kenneth Stein, Kenneth A Ellenbogen, Larisa G Tereshchenko

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in JACC. Clinical electrophysiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00677014 (SMARTDELAY Determined AV Optimization), which is not on this map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00677014 phase4completednot on this map

SMARTDELAY Determined AV Optimization: A Comparison to Other AV Delay Methods Used in Cardiac Resynchronization Therapy

TypeinterventionalSponsorBoston Scientific CorporationRan2008 to 2010Enrolled1,060ConditionsHeart FailureArmsAV Delay programming through cardiac resynchronization therapy
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Artificial intelligence in heart failure.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Primer on Machine Learning in Electrophysiology.Arrhythmia & electrophysiology review · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. REPLY: Reshaping Patient Outcomes With Machine Learning.JACC. Clinical electrophysiology · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Stacey J HowellKnight Cardiovascular Institute, Oregon Health and Science University, Portland, Oregon, USA.
Tim StivlandBoston Scientific, Marlborough, Massachusetts, USA.
Kenneth SteinBoston Scientific, Marlborough, Massachusetts, USA.
Kenneth A EllenbogenMedical College of Virginia/Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
Larisa G TereshchenkoKnight Cardiovascular Institute, Oregon Health and Science University, Portland, Oregon, USA; Cardiovascular Division, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA. Electronic address: tereshch@ohsu.edu.

Funding

Novel ECG Measures and Risk of Sudden Cardiac DeathR01HL118277 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI TERESHCHENKO, LARISA GENNADIEVNA · 2013 to 2016
$1.5M
Novel ECG measures and risk of sudden cardiac deathR56HL118277 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI TERESHCHENKO, LARISA GENNADIEVNA · 2018 to 2018
$396k
American Heart Association-American Stroke Association 17GRNT33670428NHLBI NIH HHS R01 HL118277NHLBI NIH HHS R56 HL118277
6 · The paper itself

Abstract

objectivesThis study aimed to apply machine learning (ML) to develop a prediction model for short-term cardiac resynchronization therapy (CRT) response to identifying CRT candidates for early multidisciplinary CRT heart failure (HF) care.

backgroundMultidisciplinary optimization of cardiac resynchronization therapy (CRT) delivery can improve long-term CRT outcomes but requires substantial staff resources.

methodsParticipants from the SMART-AV (SmartDelay-Determined AV Optimization: Comparison of AV Optimization Methods Used in Cardiac Resynchronization Therapy [CRT]) trial (n = 741; age: 66 ± 11 years; 33% female; 100% New York Heart Association HF functional class III-IV; 100% ejection fraction ≤35%) were randomly split into training/testing (80%; n = 593) and validation (20%; n = 148) samples. Baseline clinical, electrocardiographic, echocardiographic, and biomarker characteristics, and left ventricular (LV) lead position (43 variables) were included in 8 ML models (random forests, convolutional neural network, lasso, adaptive lasso, plugin lasso, elastic net, ridge, and logistic regression). A composite of freedom from death and HF hospitalization and a >15% reduction in LV end-systolic volume index at 6 months after CRT was the end point.

resultsThe primary end point was met by 337 patients (45.5%). The adaptive lasso model was the most more accurate (area under the receiver operating characteristic curve: 0.759; 95% CI: 0.678-0.840), well calibrated, and parsimonious (19 predictors; nearly half potentially modifiable). Participants in the 5th quintile compared with those in the 1st quintile of the prediction model had 14-fold higher odds of composite CRT response (odds ratio: 14.0; 95% CI: 8.0-14.4). The model predicted CRT response with 70% accuracy, 70% sensitivity, and 70% specificity, and should be further validated in prospective studies.

conclusionsML predicts short-term CRT response and thus may help with CRT procedure and early post-CRT care planning. (SmartDelay-Determined AV Optimization: A Comparison of AV Optimization Methods Used in Cardiac Resynchronization Therapy [CRT] [SMART-AV]; NCT00677014).

Indexed as

Cardiac Resynchronization TherapyHeart FailureAgedFemaleHumansMachine LearningMaleMiddle AgedProspective StudiesTreatment Outcomecardiac resynchronization therapymachine learning

Identifiers

PMID34454883
PMCPMC8712355

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.